The role of signal transducer and activator of transcription 5 in the inhibitory effects of GH on adipocyte differentiation

Journal of Molecular Endocrinology

Volumn 30, Issue 2, 2003, Pages 139-150

  Richter, H E ^a   Albrektsen, T ^a   Billestrup, N ^a,b  

^a NOVO NORDISK A S   (Denmark)

^b STENO DIABETES CENTER   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; FATTY ACID BINDING PROTEIN; GROWTH HORMONE; JANUS KINASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; STAT5 PROTEIN; STAT5B PROTEIN; TYROSINE;

ADIPOCYTE; ADIPOSE TISSUE; ANIMAL TISSUE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL DIFFERENTIATION; CELL LINE; CELL NUCLEUS; CONTROLLED STUDY; CORRELATION FUNCTION; DATA ANALYSIS; GENE EXPRESSION; HUMAN; HUMAN CELL; MUTATIONAL ANALYSIS; NONHUMAN; PRIORITY JOURNAL; PROADIPOCYTE; PROTEIN DNA BINDING; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; RAT; REPORTER GENE; SIGNAL TRANSDUCTION; TRANSACTIVATION;

ADIPOCYTES; ANIMALS; CARRIER PROTEINS; CELL DIFFERENTIATION; CELLS, CULTURED; DNA-BINDING PROTEINS; FATTY ACID-BINDING PROTEINS; GENE EXPRESSION REGULATION; GENES, REPORTER; GROWTH HORMONE; HUMANS; JANUS KINASE 2; MILK PROTEINS; NUCLEAR PROTEINS; PHOSPHORYLATION; PROMOTER REGIONS (GENETICS); PROTEIN ISOFORMS; PROTEIN-TYROSINE KINASES; PROTO-ONCOGENE PROTEINS; RATS; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RNA, MESSENGER; SIGNAL TRANSDUCTION; STAT5 TRANSCRIPTION FACTOR; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS; TYROSINE;

EID: 0038025842     PISSN: 09525041     EISSN: None     Source Type: Journal    
DOI: 10.1677/jme.0.0300139     Document Type: Article

References (64)

1. Adams M, Reginato MJ, Shao D, Lazar MA & Chatterjee VK 1997 Transcriptional activation by peroxisome proliferator-activated receptor gamma is inhibited by phosphorylation at a consensus mitogen-activated protein kinase site. Journal of Biological Chemistry 272 5128-5132.
2. Argetsinger LS, Campbell GS, Yang X, Witthuhn BA, Silvennoinen O, Ihle JN & Carter-Su C 1993 Identification of JAK2 as a growth hormone receptor-associated tyrosine kinase. Cell 74 237-244.
3. Campbell GS, Meyer DJ, Raz R, Levy DE, Schwartz J & Carter-Su C 1995 Activation of acute phase response factor (APRF)/Stat3 transcription factor by growth hormone. Journal of Biological Chemistry 270 3974-3979.
4. Carter-Su C, Stubbar JR, Wang XY, Stred SE, Argetsinger LS & Shafer JA 1989 Phosphorylation of highly purified growth hormone receptors by a growth hormone receptor-associated tyrosine kinase. Journal of Biological Chemistry 264 18654-18661.
5. Chakravarti D, Lamorte VJ, Nelson MC, Nakajima T, Schulman IG, Juguilon H, Montminy M & Evans RM 1996 Role of CBP/p300 in nuclear receptor signalling. Nature 383 99-103.
6. Chen C & Okayama H 1987 High-efficiency transformation of mammalian cells by plasmid DNA. Molecular and Cellular Biology 7 2745-2752.
7. Christy RJ, Yang VW, Ntambi JM, Geiman DE, Landschulz WH, Friedman AD, Nakabeppu Y, Kelly TJ & Lane MD 1989 Differentiation-induced gene expression in 3T3-L1 preadipocytes: CCAAT/enhancer binding protein interacts with and activates the promoters of two adipocyte-specific genes. Genes and Development 3 1323-1335.
8. Clarkson RW, Chen CM, Harrison S, Wells C, Muscat GE & Waters MJ 1995 Early responses of trans-activating factors to growth hormone in preadipocytes: differential regulation of CCAAT enhancer-binding protein-beta (C/EBP beta) and C/EBP delta. Molecular Endocrinology 9 108-120.
9. Donahue LR & Beamer WG 1993 Growth hormone deficiency in 'little' mice results in aberrant body composition, reduced insulin-like growth factor-I and insulin-like growth factor-binding protein-3 (IGFBP-3), but does not affect IGFBP-2, -1 or -4. Journal of Endocrinology 136 91-104.
10. Eisen EJ, Peterson CB, Parker IJ & Murray JD 1998 Effects of zinc ion concentration on growth, fat content and reproduction in oMT1a-oGH transgenic mice. Growth, Development, and Aging 62 173-186
11. Fajas L, Schoonjans K, Gelman L, Kim JB, Najib J, Martin G, Fruchart JC, Briggs M, Spiegelman BM & Auwrex J 1999 Regulation of peroxisome proliferator-activated receptor gamma expression by adipocyte differentiation and determination factor 1/ sterol regulatory element binding protein 1. Implications for adipocyte differentiation and metabolism. Molecular and Cellular Biology 19 5495-5503.
12. Font de J, Porras A, Ahn N & Santos E 1997 Mitogen-activated protein kinase activation is not necessary for, but antagonizes, 3T3-L1 adipocytic differentiation. Molecular and Cellular Biology 17 6068-6075.
13. Forman BM, Tontonoz P, Chen J, Brun RP, Spiegelman BM & Evans RM 1995 15-deoxy-delta(12,14)-prostaglandin j(2) is a ligand for the adipocyte determination factor PPAR-gamma. Cell 83 803-812.
14. Freytag SO, Paielli DL, & Gilbert JD 1994 Ectopic expression of the CCAAT/enhancer-binding protein alpha promotes the adipogenic program in a variety of mouse fibroblastic cells. Genes and Development 8 1654-1663.
15. Frick F, Bohlooly Y, Linden D, Olsson B, Tornell J, Eden S & Oscarssons J 2001 Long-term growth hormone excess induces marked alterations in lipoprotein metabolism in mice. American Journal of Physiology. Endocrinology and Metabolism 281 E1230 E1239.
16. Galsgaard ED, Gouilleux F, Groner B, Serup P, Nielsen JH & Billestrup N 1996 Identification of a growth hormone-responsive STAT5-binding element in the rat insulin-1 gene. Molecular Endocrinology 10 652-660.
17. Ge K, Guermah M, Yuan CX, Ito M, Wallberg AE, Spiegelman BM & Roeder RG 2002 Transcription coactivator TRAP220 is required for PPAR gamma 2-stimulated adipogenesis. Nature 417 563-567.
18. Gelman L, Zhou GC, Fajas L, Raspe E, Fruchart JC & Auwerx J 1999 p300 interacts with the N- and C-terminal part of PPAR gamma 2 in a ligand-independent and -dependent manner, respectively. Journal of Biological Chemistry 274 7681-7688.
19. Gouilleux F, Wakao H, Mundt M & Groner B 1994 Prolactin induces phosphorylation of Tyr694 of Stat5 (MGF), a prerequisite for DNA binding and induction of transcription. EMBO Journal 13 4361-4369.
20. Graves RA, Tontonoz P, Ross SR & Spiegelman BM 1991 Identification of a potent adipocyte-specific enhancer: involvement of an NF-1-like factor. Genes and Development 5 428-437.
21. Graves RA, Tontonoz P & Spiegelman BM 1992 Analysis of a tissue-specific enhancer: ARF6 regulates adipogenic gene expression. Molecular and Cellular Biology 12 3313.
22. Gronowski AM, Zhong Z, Wen Z, Thomas MJ, Darnell JE & Rotwein P 1995 In vivo growth hormone treatment rapidly stimulates the tyrosine phosphorylation and activation of Stat3. Molecular Endocrinology 9 171-177.
23. Hansen JA, Hansen LH, Kopchick JJ, Gouilleux F, Groner B, Nielsen JH, Perregaard AM, Galsgaard ED & Billestrup N 1997 The role of growth hormone receptor tyrosine phosphorylation in Stat5 activation. Journal of Molecular Endocrinology 18 213-221.
24. Hansen LH, Madsen B, Teisner B, Nielsen JH & Billestrup N 1998 Characterization of the inhibitory effect of growth-hormone on primary preadipocyte differentiation. Molecular Endocrinology 12 1140-1149.
25. Harp JB, Franklin D, Vanderpuije AA & Gimble JM 2001 Differential expression of signal transducers and activators of transcription during human adipogenesis. Biochemical and Biophysical Research Communication 281 907-912.
26. Ihle JN 2001 The Stat family in cytokine signaling. Current Opinion in Cellular Biology 13 211-217.
27. Ikeda A, Chang KT, Matsumoto Y, Furuhata Y, Nishihara M, Sasaki F & Takahashi M 1998 Obesity and insulin-resistance in human growth-hormone transgenic rats. Endocrinology 139 3057-3063.
28. Johannsson G, Marin P, Lonn L, Ottosson M, Stenlof K, Bjorntorp P, Sjostrom L & Bengtsson BA 1997 Growth hormone treatment of abdominally obese men reduces abdominal fat mass, improves glucose and lipoprotein metabolism, and reduces diastolic blood pressure. Journal of Clinical Endocrinology and Metabolism 82 727-734.
29. Kamei Y, Xu L, Heinzel T, Torchia J, Kurokawa R, Gloss B, Lin SC, Heyman RA, Rose DW, Glass CK et al. 1996 A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors. Cell 85 403-414.
30. Lauterio TJ, Barkan A, DeAngelo M, DeMott-Friberg R & Ramirez R 1998 Plasma growth hormone secretion is impaired in obesity-prone rats before onset of diet-induced obesity. American Journal of Physiology 275 E6 E11.
31. Lehmann JM, Moore LB, Smith-Oliver TA, Wilkison WO, Willson TM & Kliewer SA 1995 An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma). Journal of Biological Chemistry 270 12953-12956.
32. Luo G & Yu-Lee L 2000 Stat5b inhibits NFkappaB-mediated signaling. Molecular Endocrinology 14 114-123.
33. Lou G & Yu-Lee L 1997 Transcriptional inhibition by stat5 - differential activities at growth-related versus differentiation-specific promoters. Journal of Biological Chemistry 272 26841-26849.
34. Meyer DJ, Campbell GS, Cochran BH, Argetsinger LS, Larner AC, Finbloom DS, Carter-Su C & Schwartz J 1994 Growth hormone induces a DNA binding factor related to the interferon-stimulated 91-kDa transcription factor. Journal of Biological Chemistry 269 4701-4704.
35. Morikawa M, Nixon T & Green H 1982 Growth hormone and the adipose conversion of 3T3 cells. Cell 29 783-789.
36. Nanbu-Wakao R, Fujitani Y, Masuho Y, Muramatu M & Wakao H 2000 Prolactin enhances CCAAT enhancer-binding protein-beta (C/EBP beta) and peroxisome proliferator-activated receptor gamma (PPAR gamma) messenger RNA expression and stimulates adipogenic conversion of NIH-3T3 cells. Molecular Endocrinology 14 307-316.
37. Nanbu-Wakao R, Morikawa Y, Matsumura I, Masuho Y, Muramatsu MA, Senba E & Wakao H 2002 Stimulation of 3T3-L1 adipogenesis by signal transducer and activator of transcription 5. Molecular Endocrinology 16 1565-1576.
38. Pfitzner E, Jahne R, Wissler M, Stoecklin E & Groner B 1998 P300/CREB-binding protein enhances the prolactin-mediated transcriptional induction through direct interaction with the transactivation domain of stat5, but does not participate in the stat5-mediated suppression of the glucocorticoid response. Molecular Endocrinology 12 1582-1593.
39. Pomp D, Oberbauer AM & Murray JD 1996 Development of obesity following inactivation of a growth-hormone transgene in mice. Transgenic Research 5 13-23.
40. Rosen ED, Sarraf P, Troy AE, Bradwin G, Moore K, Milstone DS, Spiegelman BM & Mortensen RM 1999 PPAR gamma is required for the differentiation of adipose tissue in vivo and in vitro. Molecular Cell 4 611-617.
41. Rosen ED, Walkey CJ, Puigserver P & Spiegelman BM 2000 Transcriptional regulation of adipogenesis. Genes and Development 14 1293-1307.
42. Salomon F, Cuneo RC, Hesp Ri & Sonksen PH 1989 The effects of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency. New England Journal of Medicine 321 1797-1803.
43. Schoonjans K, Peinado-Onsurbe J, Lefebvre AM, Heyman RA, Briggs M. Deeb S, Staels B & Auwerx J 1996 PPARalpha and PPARgamma activators direct a distinct tissue-specific transcriptional response via a PPRE in the lipoprotein lipase gene. EMBO Journal 15 5336-5348.
44. Smit LS, Meyer DJ, Billestrup N, Norstedt G, Schwartz J & Carter-Su C 1996 The role of the growth hormone (GH) receptor and JAK1 and JAK2 kinases in the activation of Stats 1, 3, and 5 by GH. Molecular Endocrinology 10 519-533.
45. Smit LS, Vanderkuur JA, Stimage A, Han Y, Luo G, Yu-Lee LY, Schwartz J & Carter-Su C 1997 Growth hormone-induced tyrosyl phosphorylation and deoxyribonucleic acid binding activity of Stat5A and Stat5B. Endocrinology 138 3426-3434.
46. Stephens JM, Morrison RF & Pilch RF 1996 The expression and regulation of STATs during 3T3-L1 adipocyte differentiation. Journal of Biological Chemistry 271 10411-10444.
47. Stephens JM, Morrison RF, Wu Z & Farmer SR 1999 PPARgamma ligand-dependent induction of STAT1, STAT5A, and STAT5B during adipogenesis. Biochemical and Biophysical Research Communications 262 216-222.
48. Stocklin E, Wissler M, Gouilleux F & Groner B 1996 Functional interactions between stat5 and the glucocorticoid receptor. Nature 383 726-728.
49. Teglund S, Mckay C, Schuetz E, Vandeursen JM, Stravopodis D, Wang DM, Brown M, Bodner S, Grosveld G & Ihle JN 1998 Stat5a and stat5b proteins have essential and nonessential, or redundant, roles in cytokine responses. Cell 93 841-850.
50. Tontonoz P, Graves RA, Budavari AI, Erdjument-Bromage H, Lui M, Hu E, Tempst P & Spiegelman BM 1994a Adipocyte-specific transcription factor ARF6 is a heterodimeric complex of two nuclear hormone receptors, PPAR gamma and RXR alpha. Nucleic Acids Research 22 5628-5634.
51. Tontonoz P, Hu E, Graves RA, Budavari AI & Spiegelman BM 1994b mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer. Genes and Development 8 1224-1234.
52. Tontonoz P, Hu E & Spiegelman BM 1994c Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor. Cell 79 1147-1156.
53. Tontonoz P, Hu E, Devine J, Beale EG & Spiegelman BM 1995 PPAR gamma 2 regulates adipose expression of the phosphoenolypruvate carboxykinase gene. Molecular and Cellular Biology 15 351-357.
54. de Vos AM, Ultsch M & Kossiakoff AA 1992 Human growth hormone and extracellular domain of its receptor: crystal Structure of the complex. Science 255 306-312.
55. Wabitsch M, Braun S, Hauner H, Heinze E, Ilondo MM, Shymko R, Demeyts P & Teller WM 1996 Mitogenic and antiadipogenic properties of human growth-hormone in differentiating human adipocyte precursor cells in primary culture. Pediatric Research 40 450-456.
56. Wood TJ, Sliva D, Lobie PE, Pircher TJ, Gouilleux F, Wakao H, Gustafsson JA, Groner B, Norstedt G & Haldosen LA 1995 Mediation of growth hormone-Dependent transcriptional activation by mammary gland factor/Stat 5. Journal of Biological Chemistry 270 9448-9453.
57. Wu Z, Rosen, ED, Brun R, Hauser S, Adelmant G, Troy AE, McKeon C, Darlington GJ & Spiegelman BM 1999 Cross-regulation of C/EBP alpha and PPAR gamma controls the transcriptional pathway of adipogenesis, and insulin sensitivity. Molecular Cell 3 151-158.
58. Xu BC, Chen WY, Gu T, Ridgway D, Wiehl P, Okada S & Kopchick JJ 1995 Effects of growth-hormone antagonists on 3T3-F442A preadipocyte differentiation. Journal of Endocrinology 146 131-139.
59. Yamauchi T, Waki H, Kamon J, Murakami K, Motojima K, Komeda K, Miki H, Kubota N, Terauchi Y, Tsuchida A et al. 2001 Inhibition of RXR and PPARgamma ameliorates diet-induced obesity and type 2 diabetes. Journal of Clinical Investigation 108 1001-1013.
60. Yarwood SJ, Sale EM, Sale GJ. Houslay MD, Kilgour E & Anderson NG 1999 Growth hormone-dependent differentiation of 3T3-F442A preadipocytes requires Janus kinase/signal transducer and activator of transcription but not mitogen-activated protein kinase or p70 S6 kinase signaling. Journal of Biological Chemistry 274 8662-8668.
61. Zhang JJ, Vinkemeier U, Gu W, Chakravarti D, Horvath CM & Darnell JE 1996 Two contact regions between Stat1 and CBP/ p300 in interferon gamma signaling. PNAS 93 15092-15096.
62. Zhou YC & Waxman DJ 1999a Cross-talk between janus kinase-signal transducer and activator of transcription (JAK-STAT) and peroxisome proliferator-activated receptor-alpha (PPARalpha) Signaling pathways. Growth hormone inhibition of pparalpha transcriptional activity Mediated by stat5b. Journal of Biological Chemistry 274 2672-2681.
63. Zhou YC & Waxman DJ 1999b STAT5b down-regulates peroxisome proliferator-activated receptor alpha transcription by inhibition of ligand-independent activation function region-1 trans-activation domain. Journal of Biological Chemistry 274 29874-29882.
64. Zhu Y, Qi C, Jain S, Rao, MS & Reddy JK 1997 Isolation and characterization of PBP, a protein that interacts with peroxisome proliferator-activated receptor. Journal of Biological Chemistry 272 25500-25506.